Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2015

Pharma News, 2015

Lupin raises diabetes drug price by 200%
Lupin raises diabetes drug price by 200%
Lupin has hiked the price of its anti diabetes drug in the US market by 200 percent.
Regen Biopharma Inc. Initiates Small Molecule Hit Validation Study on Cancer Stem Cell Target Gene
Regen Biopharma Inc. Initiates Small Molecule Hit Validation Study on Cancer Stem Cell Target Gene
Regen BioPharma Inc.
Stanford team re-engineers virus to deliver therapies to cells
Stanford team re-engineers virus to deliver therapies to cells
Stanford Report, September 21, 2015.
Pharmaxis Releases Successful Results of Phase 1 Clinical Trial for Boehringer Ingelheim Partnered Drug PXS-4728A
Pharmaxis Releases Successful Results of Phase 1 Clinical Trial for Boehringer Ingelheim Partnered Drug PXS-4728A
SYDNEY, Australia, September 21, 2015.
Inovio secures $24m option grant from DARPA to advance Ebola program development
Inovio secures $24m option grant from DARPA to advance Ebola program development
The US Defense Advanced Research Projects Agency (DARPA) has exercised its option to provide an additional $24 million to support the Inovio Pharmaceuticals-led development of multiple treatme...
Perrigo rejects Mylan's unsolicited exchange offer as inadequate
Perrigo rejects Mylan's unsolicited exchange offer as inadequate
Perrigo said that its Board of Directors has reviewed Mylan's unsolicited tender offer to acquire all of the outstanding shares of Perrigo and, in consultation with its financial and legal advisor...
GlobalData says world HIV therapeutics market to reach $15.3 bn by 2023
GlobalData says world HIV therapeutics market to reach $15.3 bn by 2023
The value of the human immunodeficiency virus (HIV) treatment market will increase marginally from just over $14 billion in 2013 to approach $15.
Old drug performs new tricks
Old drug performs new tricks
Patients with the most dangerous type of high blood pressure will be able to receive far more effective treatment after Cambridge-led research reveals the powers of a "wonder drug" that has ...
Old drug offers new hope to treat Alzheimer's disease
Old drug offers new hope to treat Alzheimer's disease
Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal de...
Intas Pharma expects U.S. approval for Neulasta biosimilar this year
Intas Pharma expects U.S. approval for Neulasta biosimilar this year
MUMBAI, 18 Sept.
Amgen agrees to buy Dutch firm Dezima Pharma in $1.55bn deal
Amgen agrees to buy Dutch firm Dezima Pharma in $1.55bn deal
Amgen has entered a definitive acquisition agreement with Dutch biotechnology firm Dezima Pharma for $1.
Purdue University-Based Pharmaceutical Startup To Participate In American Chemical Society
Purdue University-Based Pharmaceutical Startup To Participate In American Chemical Society
WEST LAFAYETTE, Ind.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand